moxonidine has been researched along with Uremia in 1 studies
moxonidine: structure given in first source
Uremia: A clinical syndrome associated with the retention of renal waste products or uremic toxins in the blood. It is usually the result of RENAL INSUFFICIENCY. Most uremic toxins are end products of protein or nitrogen CATABOLISM, such as UREA or CREATININE. Severe uremia can lead to multiple organ dysfunctions with a constellation of symptoms.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dikow, R | 1 |
Kihm, LP | 1 |
Zeier, M | 1 |
Kapitza, J | 1 |
Törnig, J | 1 |
Amann, K | 1 |
Tiefenbacher, C | 1 |
Ritz, E | 1 |
1 other study available for moxonidine and Uremia
Article | Year |
---|---|
Increased infarct size in uremic rats: reduced ischemia tolerance?
Topics: Animals; Body Weight; Coronary Vessels; Heart Ventricles; Hydralazine; Imidazoles; Ischemia; Male; M | 2004 |